Growth Metrics

Quest Diagnostics (DGX) Receivables - Other (2016 - 2021)

Quest Diagnostics' Receivables - Other history spans 9 years, with the latest figure at $5.0 million for Q1 2021.

  • On a quarterly basis, Receivables - Other changed 0.0% to $5.0 million in Q1 2021 year-over-year; TTM through Mar 2021 was $5.0 million, a 0.0% change, with the full-year FY2020 number at $3.0 million, down 25.0% from a year prior.
  • Receivables - Other hit $5.0 million in Q1 2021 for Quest Diagnostics, up from $3.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for DGX hit a ceiling of $13.0 million in Q2 2017 and a floor of $2.0 million in Q1 2019.
  • Historically, Receivables - Other has averaged $4.6 million across 5 years, with a median of $4.0 million in 2018.
  • Biggest five-year swings in Receivables - Other: crashed 76.92% in 2018 and later surged 150.0% in 2020.
  • Tracing DGX's Receivables - Other over 5 years: stood at $3.0 million in 2017, then changed by 0.0% to $3.0 million in 2018, then soared by 33.33% to $4.0 million in 2019, then fell by 25.0% to $3.0 million in 2020, then surged by 66.67% to $5.0 million in 2021.
  • Business Quant data shows Receivables - Other for DGX at $5.0 million in Q1 2021, $3.0 million in Q4 2020, and $4.0 million in Q3 2020.